YY/T 1754.2-2020Preclinical animal study of medical devices - Part 2: Model of skin defect in induced diabetic rats (English PDF)
医疗器械临床前动物研究 第2部分:诱导糖尿病大鼠皮肤缺损模型
This is a limited preview
Buy now to download the full PDF (24 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1754.2-2020 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
September 27, 2020
Implementation date
September 1, 2021
Scope
YY/T 1754.2-2020 is the English-translated version of 医疗器械临床前动物研究 第2部分:诱导糖尿病大鼠皮肤缺损模型.
YY/T 1754.2-2020 is the Chinese pharmaceutical industry standard that describes how a skin defect model is built in the induced diabetic rat, the model used to evaluate the preclinical effectiveness of devices intended for hard-to-heal wounds.
It is the second part of the YY/T 1754 series and sets out the induction and confirmation of the diabetic state, the making and the size of the defect, the care of the animals, the application of the test article and the controls, and the measurements by which healing is judged. Issued on 27 September 2020, it has applied since 1 September 2021.
Found what you need?
Document preview — YY/T 1754.2-2020
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- Introduction4
- 1 Scope5
- 2 Normative references5
- 3 Experimental principle5
- 4 Apparatus and reagents5
- 5 Test animal6
- 6 Test process6
- 7 Test report8
- Appendix A (Informative) Examples of histological semi-quantitative analysis methods of model of skin defect in induced diabetic rats9
1 Scope
This Part of YY/T 1754 specifies the method for constructing a model of skin defect in induced diabetic rats.
This Part applies to the evaluation of the preclinical effectiveness of medical device products for the treatment of skin ulcers and damage caused by diabetes.
2 Normative references
The following documents are indispensable for the application of this document.
For dated references, only the dated version applies to this document. For undated references, the latest edition (including all amendments) applies to this document.
GB/T 16886.2, Biological evaluation of medical devices - Part 2: Animal welfare requirements
3 Experimental principle
Induce rat diabetes by injection of streptozotocin (STZ); excise the back skin of diabetic rats to construct a skin defect model of diabetic rats.
4 Apparatus and reagents
4.2 Reagents
4.2.2 Sodium citrate (analytical reagent)
One day after the successful establishment of the diabetic rat model, begin to establish the skin injury model. After anesthesia, place the rat on the operating table, with the back facing up; remove the back hair, to fully expose the back skin. After routine surgical disinfection, remove the 2 cm × 2 cm full-thickness skin from the back of the rat (other verified wounds are also available).
6 Test process
6.1.4 Test product sampling
The test rats should be randomly divided into a blank control group, a test product group, and/or a control product group (such as a commercially available product); the number of each group shall meet the requirements of statistical analysis. For the blank control group, only use sterile gauze/applicator to cover the skin wound on the back of the rat and fix, without other treatment; for the test product group and/or control group, use the relevant test product and/or control substance to cover the skin would on the back of the rat, and use sterile gauze/applicator to cover and fix. All animals are raised in single cages.
Observe the activities and diet of the animals every day, and replace the litter in time.
6.2 Test result and evaluation
6.2.1 General
The recommended observation period is at least 21 days. Select a reasonable observation time point according to the product characteristics. At least include the observation indicators of 6.2.2 ~ 6.2.4.
6.2.2 General wound recovery
It is advisable to roughly judge the recovery of the wound through the exudation, adhesion and wound retraction of the rat's wound.
6.2.3 Wound healing rate
The time point should be observed after the operation; take pictures of the wound; use image processing software or other verified software to measure the wound area. Wound healing rate is the ratio of the difference between the original wound area and the unhealed area of the wound to the original wound area. See Formula (1) for the calculation of wound healing rate:
Where: R -- Wound healing rate;
A0 -- Original area of the wound, in square centimeters (mm2);
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 24 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1754.2-2020
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.2-2011 — Biological evaluation of medical devices -- Part 2: Animal welfare requirements
GB/T 16886.2-2026 — Biological evaluation of medical devices - Part 2: Animal welfare requirements
YY/T 1754.3-2023 — Preclinical animal studies of medical devices - Part 3: Animal abdominal wall incision model for evaluating the histological response and biomechanical performance of surgical mesh
Secure payment via Stripe
Payments accepted
YY/T 1754.2-2020
$165.00